Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Tedim-Moreira J"'
Autor:
Costa-Pinto S; Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal., Gonçalves-Ribeiro J; Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal., Tedim-Moreira J; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular (IBMC), University of Porto, Porto 4200-135, Portugal; Department of Biomedicine, Faculty of Medicine, University of Porto, Porto 4200-135, Portugal., Socodato R; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular (IBMC), University of Porto, Porto 4200-135, Portugal., Relvas JB; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular (IBMC), University of Porto, Porto 4200-135, Portugal; Department of Biomedicine, Faculty of Medicine, University of Porto, Porto 4200-135, Portugal., Sebastião AM; Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal., Vaz SH; Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal. Electronic address: svaz@medicina.ulisboa.pt.
Publikováno v:
Neurobiology of disease [Neurobiol Dis] 2024 Apr; Vol. 193, pp. 106435. Date of Electronic Publication: 2024 Feb 07.
Autor:
Socodato R; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. Electronic address: renato.socodato@ibmc.up.pt., Almeida TO; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; ICBAS - School of Medicine and Biomedical Sciences, Porto, Portugal., Portugal CC; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Santos ECS; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; Department of Biomedicine, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Tedim-Moreira J; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; Department of Biomedicine, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Galvão-Ferreira J; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; Department of Biomedicine, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Canedo T; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Baptista FI; Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra Institute for Clinical and Biomedical Research (iCBR), and Clinical Academic Center of Coimbra (CACC), University of Coimbra, Coimbra, Portugal., Magalhães A; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Ambrósio AF; Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra Institute for Clinical and Biomedical Research (iCBR), and Clinical Academic Center of Coimbra (CACC), University of Coimbra, Coimbra, Portugal., Brakebusch C; Molecular Pathology Section, BRIC, Københavns Biocenter, Copenhagen, Denmark., Rubinstein B; Stowers Institute for Medical Research, Kansas City, MO, USA., Moreira IS; Department of Life Sciences, Center for Innovative Biomedicine and Biotechnology (CIBB) and CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal., Summavielle T; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; ESS.PP, Escola Superior de Saúde do Politécnico do Porto, Porto, Portugal., Pinto IM; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; Department of Biomedicine, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Relvas JB; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal; Department of Biomedicine, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal. Electronic address: jrelvas@ibmc.up.pt.
Publikováno v:
Cell reports [Cell Rep] 2023 Dec 26; Vol. 42 (12), pp. 113447. Date of Electronic Publication: 2023 Nov 18.
Autor:
Socodato R; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. renato.socodato@ibmc.up.pt., Rodrigues-Santos A; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Tedim-Moreira J; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Almeida TO; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal.; ICBAS - School of Medicine and Biomedical Sciences, Porto, Portugal., Canedo T; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Portugal CC; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Relvas JB; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. jrelvas@ibmc.up.pt.; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal. jrelvas@ibmc.up.pt.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Dec 08; Vol. 14 (12), pp. 808. Date of Electronic Publication: 2023 Dec 08.
Autor:
Socodato R; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. renato.socodato@ibmc.up.pt., Rodrigues-Santos A; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Tedim-Moreira J; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Almeida TO; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal.; ICBAS - School of Medicine and Biomedical Sciences, Porto, Portugal., Canedo T; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Portugal CC; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Relvas JB; Institute of Research and Innovation in Health (i3S) and Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. jrelvas@ibmc.up.pt.; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal. jrelvas@ibmc.up.pt.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Oct 20; Vol. 14 (10), pp. 690. Date of Electronic Publication: 2023 Oct 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daga, Kanupriya R.1,2 (AUTHOR), Larey, Andrew M.1,2 (AUTHOR), Morfin, Maria G.1 (AUTHOR), Chen, Kailin2,3 (AUTHOR), Bitarafan, Sara4,5 (AUTHOR), Carpenter, Jana M.6 (AUTHOR), Hynds, Hannah M.6 (AUTHOR), Hines, Kelly M.6 (AUTHOR), Wood, Levi B.4,5 (AUTHOR), Marklein, Ross A.1,2,7 (AUTHOR) ross.marklein@fda.hhs.gov
Publikováno v:
Journal of Biological Engineering. 10/17/2024, Vol. 18 Issue 1, p1-21. 21p.
Autor:
Zou, Ju1,2,3 (AUTHOR), Li, Jie1,2,3 (AUTHOR), Wang, Xiaoxu1,2,3 (AUTHOR), Tang, Daolin4 (AUTHOR), Chen, Ruochan1,2,3 (AUTHOR) 405031@csu.edu.cn
Publikováno v:
Journal of Neuroinflammation. 8/1/2024, Vol. 21 Issue 1, p1-25. 25p.
Autor:
Socodato R; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal. renato.socodato@ibmc.up.pt tsummavi@ibmc.up.pt jrelvas@ibmc.up.pt., Henriques JF; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Portugal CC; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Almeida TO; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Tedim-Moreira J; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Alves RL; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Canedo T; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal.; Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal., Silva C; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Magalhães A; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal., Summavielle T; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal. renato.socodato@ibmc.up.pt tsummavi@ibmc.up.pt jrelvas@ibmc.up.pt., Relvas JB; Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal. renato.socodato@ibmc.up.pt tsummavi@ibmc.up.pt jrelvas@ibmc.up.pt.; Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Publikováno v:
Science signaling [Sci Signal] 2020 Sep 22; Vol. 13 (650). Date of Electronic Publication: 2020 Sep 22.
Autor:
Monteiro-Reis S; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain., Blanca A; Department of Urology, University Hospital of Reina Sofia, Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain., Tedim-Moreira J; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain., Carneiro I; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Montezuma D; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Monteiro P; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Oliveira J; Department of Urology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal., Antunes L; Department of Epidemiology, Portuguese Oncology Institute of Porto (IPO Porto) & Cancer Epidemiology Group-Research Center (CI-IPOP), 4200-072 Porto, Portugal., Henrique R; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Urology, University Hospital of Reina Sofia, Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS)-University of Porto, 4050-313 Porto, Portugal., Lopez-Beltran A; Department of Surgery and Pathology, Faculty of Medicine, University of Cordoba, 14071 Cordoba, Spain.; Champalimaud Clinical Center, 1400-038 Lisbon, Portugal., Jerónimo C; Cancer Biology and Epigenetics Group-Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), and Porto Comprehensive Cancer Center (P.CCC), Maimonides Biomedical Research Institute of Cordoba, 14004 Cordoba, Spain.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS)-University of Porto, 4050-313 Porto, Portugal.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2020 Feb 24; Vol. 9 (2). Date of Electronic Publication: 2020 Feb 24.